Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Guannan Niu"'
Autor:
Wence Shi, Dejing Feng, Xiangming Hu, Can Wang, Guannan Niu, Zhenyan Zhao, Hongliang Zhang, Moyang Wang, Yongjian Wu
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 21 (2024)
Background The mechanism for hypoattenuating leaflet thickening (HALT) after transcatheter aortic valve replacement is still not well elucidated, and the role of Lp(a) (lipoprotein[a]) and hs‐CRP (high‐sensitivity C‐reactive protein) has rarely
Externí odkaz:
https://doaj.org/article/788ca06153cd48a7a850a6fd0cbc8328
Autor:
Xiangming Hu, Dejing Feng, Yuxuan Zhang, Can Wang, Yang Chen, Guannan Niu, Zheng Zhou, Zhenyan Zhao, Hongliang Zhang, Moyang Wang, Yongjian Wu
Publikováno v:
Cardiovascular Diabetology, Vol 23, Iss 1, Pp 1-10 (2024)
Abstract Background Stress hyperglycemia ratio (SHR) has recently been recognized as a novel biomarker that accurately reflects acute hyperglycemia status and is associated with poor prognosis of heart failure. We evaluated the relationship between S
Externí odkaz:
https://doaj.org/article/88b92e58ce65406b80a1ec21057bc2ae
Autor:
Jian Yang, Yang Wang, Yan Wang, Can Wang, Yang Chen, Yi Li, Haibo Zhang, Haiyan Xu, Nan Jiang, Yongjian Wu, Kai Xu, Guosheng Fu, Zhenfei Fang, Yunqing Ye, Xiangming Hu, Daxin Zhou, Qifeng Zhu, Junjie Zhang, Yingqiang Guo, Moyang Wang, Dejing Feng, Guannan Niu, Erli Zhang
Publikováno v:
BMJ Open, Vol 13, Iss 11 (2023)
Introduction The strategy for initiating antithrombotic therapy to prevent bioprosthetic valve thrombosis (BPVT) after transcatheter aortic valve replacement (TAVR) remains uncertain. There is still lacking evidence on the efficacy and safety of earl
Externí odkaz:
https://doaj.org/article/6f21d43d3bf641c895e79c53254766b3
Autor:
Moyang Wang, Guannan Niu, Yang Chen, Zheng Zhou, Dejing Feng, Yuxuan Zhang, Yongjian Wu, Guangyuan Song, Haibo Zhang, Daxin Zhou, Fang Wang, Changfu Liu, Bo Yu, Kai Xu, Zongtao Yin, Hongliang Cong, Nan Jiang, Pengfei Zhang, Xiquan Zhang, Jian An, Zhengming Jiang, Ling Tao, Jian Yang, Junjie Zhang, Xianxian Zhao, Fanglin Lu, Xianbao Liu, Yanqing Wu, Jianfang Luo, Lianglong Chen, Zhenfei Fang, Xiaoke Shang
Publikováno v:
EBioMedicine, Vol 96, Iss , Pp 104794- (2023)
Summary: Background: Pre-procedural computed tomography (CT) imaging assessment of the aortic valvular complex (AVC) is essential for the success of transcatheter aortic valve replacement (TAVR). However, pre-TAVR assessment is a time-intensive proce
Externí odkaz:
https://doaj.org/article/fc457b45fe764fab8df8e6a5cb9f9fdc
Autor:
Guannan Niu, Walid Ben Ali, Moyang Wang, Hasan Jilaihawi, Haitong Zhang, Qian Zhang, Yunqing Ye, Xinmin Liu, Jing Yao, Qinghao Zhao, Yubin Wang, Zheng Zhou, Lizhi Zhang, Xinshuang Ren, Yunqiang An, Bin Lu, Thomas Modine, Yongjian Wu, Guangyuan Song, Xiuyuan Hao, Rongman Jia
Publikováno v:
Chinese Medical Journal, Vol 135, Iss 24, Pp 2968-2975 (2022)
Abstract. Background:. The study aimed to describe the aortic valve morphology in Chinese patients underwent transcatheter aortic valve replacement (TAVR) for symptomatic severe aortic stenosis (AS), and the impact of sizing strategies and related pr
Externí odkaz:
https://doaj.org/article/82e1dc3580f34c8a8927d02997c80bb0
Autor:
Zhenyan Zhao, Zhen Meng, Guangyuan Song, Chunrong Wang, Sheng Shi, Jie Zhao, Hongliang Zhang, Moyang Wang, Guannan Niu, Zheng Zhou, Jianhui Wang, Yongjian Wu
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Aortic stenosis (AS) increases left ventricular afterload, leading to cardiac damage and heart failure (HF). Transcatheter aortic valve replacement (TAVR) is an effective therapy for AS. No inotropic agents including levosimendan have bee
Externí odkaz:
https://doaj.org/article/7139b3c9a69548bd9da5edc4c4b945ca
Autor:
Hongliang Zhang, Zhenyan Zhao, Jing Yao, Jie Zhao, Tao Hou, Moyang Wang, Yanlu Xu, Bincheng Wang, Guannan Niu, Yonggang Sui, Guangyuan Song, Yongjian Wu
Publikováno v:
Therapeutic Advances in Chronic Disease, Vol 13 (2022)
Background: The association between prior percutaneous coronary intervention (PCI) and prognosis after coronary artery bypass grafting (CABG) remains uncertain. We aimed to evaluate the aforementioned association in a meta-analysis. Methods: PubMed,
Externí odkaz:
https://doaj.org/article/0ded344337e54670bd971d4d23739dff
Publikováno v:
European Heart Journal - Case Reports. 6
Background Coronary obstruction (CO) is an infrequent but life-threatening complication during transcatheter aortic valve replacement (TAVR). Case summary We report the case of a patient who accepted TAVR with high anatomical risks of CO due to the s
Autor:
Hongliang Zhang, Zhenyan Zhao, Jing Yao, Jie Zhao, Tao Hou, Moyang Wang, Yanlu Xu, Bincheng Wang, Guannan Niu, Yonggang Sui, Guangyuan Song, Yongjian Wu
Publikováno v:
Therapeutic advances in chronic disease. 13
Background: The association between prior percutaneous coronary intervention (PCI) and prognosis after coronary artery bypass grafting (CABG) remains uncertain. We aimed to evaluate the aforementioned association in a meta-analysis. Methods: PubMed,
Autor:
Hanjun, Pei, Yongjian, Wu, Yuejin, Yang, Siyong, Teng, Haitao, Zhang, Lei, Zhang, Hongxia, Niu, Wenjia, Zhang, Guannan, Niu, Jie, Qian, Shubin, Qiao, Bo, Xu, Runlin, Gao
Publikováno v:
Zhonghua xin xue guan bing za zhi. 43(1)
To explore the procedural feasibility and early clinical outcomes of percutaneous balloon aortic valvuloplasty (PBAV) in patients with severe aortic stenosis, who were considered transiently unsuitable for surgical aortic valve replacement (sAVR) and